Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-12-12
2006-12-12
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S236000, C546S339000, C544S395000, C540S575000, C540S611000, C514S212010, C514S218000, C514S255030, C514S277000
Reexamination Certificate
active
07148238
ABSTRACT:
The invention provides compounds represented by the general formula Iwherein the substituents are defined in the application. The compounds are useful in the treatment of an affective disorder, including depression, anxiety disorders including general anxiety disorder and panic disorder and obsessive compulsive disorder.
REFERENCES:
patent: 4198417 (1980-04-01), Ong et al.
patent: 4198419 (1980-04-01), Ong et al.
patent: 4241071 (1980-12-01), Martin et al.
patent: 6407099 (2002-06-01), Annoura et al.
patent: 2006/0100242 (2006-05-01), Puschl et al.
patent: 0 755 923 (1997-01-01), None
patent: 1 489 711 (1977-10-01), None
patent: WO 99/17777 (1999-04-01), None
patent: WO 00/59878 (2000-10-01), None
patent: WO 01/10842 (2001-02-01), None
patent: WO-01/49678 (2001-07-01), None
patent: WO-01/49681 (2001-07-01), None
patent: WO-02/05108 (2002-08-01), None
patent: WO 02/062766 (2002-08-01), None
patent: WO 2004/085385 (2004-10-01), None
patent: WO 2005/000309 (2005-01-01), None
Lawrence L. Martin, et al. “Synthesis of Spiro[isobenzofur4an-1(3 H), 4′-piperidines] as Potential Central Nervous Systems Agents, 5. Conformationally Mobile Analogues Derived by Furan Ring Opening”, Journal of Medicinal Chemistry, 1979, vol. 22, No. 11.
Bang-Andersen Benny
Puschl Ask
Ruhland Thomas
Bernhardt Emily
H. Lundbeck A/S
LandOfFree
Phenyl-piperazine derivatives as serotonin reuptake inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenyl-piperazine derivatives as serotonin reuptake inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenyl-piperazine derivatives as serotonin reuptake inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3720445